Eli Lilly and Company (LLY)

$1,417.54 +3.19%

GREEN LIGHT — BUY Sector: Health Care Mkt Cap: $1.34T

Eli Lilly and Company (LLY) earns a Green BUY light with a 72/100 confidence score. High-quality cash engine (84% profit margin, 32% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.

Roarable Confidence Score

72 / 100

Sell <59 Hold Buy 70+

LLY // HISTORICAL PRICE & TECHNICAL WORKSTATION1Y: +64.28%

2026-10-30O $1,286.4H $1,449.7L $1,260.3C $1,417.5VOL 15.63M

SMA50: $1,197.1SMA200: $1,091.2

The 3 Simple Checks Behind LLY's BUY Rating

1. Money & Cash Health ● HEALTHY

Are profits real cash in the bank?

Real cash coming in backs up reported profits (84% profit margin and healthy balance-sheet cushion).

Sub-Score 19 / 20

2. Big Money & Insiders ● NEUTRAL

Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Sub-Score 27 / 40

3. Hidden SEC Risks 🔒 LOCKED

SEC fine-print scan & rate fit

Enter your email to reveal LLY's Hidden SEC Risk Light and get alerted the moment LLY changes rating.

Bull Case: Reasons to Like LLY

✓ Strong cash generator (84% profit margin)—profits are backed by real money, not accounting tricks.

Bear Case: Risks to Watch Out For

• Priced at 49x earnings—high expectations leave less room for a lukewarm quarter.
• Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

Institutional & SEC Scanner Spotlights on LLY

● CONTRARIAN BUY SIGNAL

Consistently wrong Wall Street analysts are bearish while business fundamentals stay strong

Analysts with poor historical timing turned cautious here even though the company’s actual cash flow and profit margins remain healthy.